The immune thrombocytopenia treatment market is estimated to be valued at USD 3.65 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 1.6% from 2025 to 2032. https://hallbook.com.br/blogs/743761/Immune-Thrombocytopenia-Treatment-Market-Size-and-Emerging-Growth-Trends